Indirect agonist

From WikiMD's WELLNESSPEDIA

Indirect agonist is a type of pharmacological agent that increases the action of a biological receptor not by binding to the primary active site, but by interacting with other sites on the same receptor. This interaction results in an increase in the natural ligand's effect on the receptor. Indirect agonists are often used in the treatment of various medical conditions, including neurological disorders and psychiatric disorders.

Mechanism of Action[edit]

The mechanism of action of an indirect agonist involves the modulation of the receptor's activity rather than direct stimulation. This is achieved by increasing the availability of the endogenous ligand, either by inhibiting its reuptake or degradation, or by increasing its release. This results in an enhanced response to the natural ligand, effectively increasing the receptor's activity.

Examples[edit]

Examples of indirect agonists include drugs like amphetamines, which increase the release of neurotransmitters such as dopamine, norepinephrine, and serotonin. Another example is cocaine, which inhibits the reuptake of these neurotransmitters, thereby increasing their availability in the synaptic cleft.

Clinical Applications[edit]

Indirect agonists have a wide range of clinical applications. They are used in the treatment of conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy, where they help to increase alertness and decrease impulsivity. They are also used in the management of Parkinson's disease, where they help to increase the levels of dopamine in the brain.

Side Effects[edit]

Like all pharmacological agents, indirect agonists can have side effects. These can include insomnia, anxiety, tachycardia, and hypertension. In some cases, they can also lead to addiction due to their impact on the reward pathways in the brain.

See Also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!